Skin cancers have traditionally been treated with surgical excision. This is the most effective treatment option, but over the last few decades non-surgical treatments have become available. These include cryotherapy, topical fluorouracil and imiquimod creams, and photodynamic therapy with methyl aminolevulinate hydrochloride. while they may sometimes have a superior cosmetic result, non-surgical treatments should not be used when the diagnosis is unclear or if follow-up is not assured.
introduction
In Australia, the number of skin cancers treated each year exceeds the total number of other cancers treated. Nonmelanoma skin cancers are the most common type and include basal and squamous cell carcinomas. Precancerous lesions (solar keratoses) are also extremely common. other rarer forms of skin cancer such as melanoma and atypical fibroxanthoma are usually surgically removed.
Surgical excision is still the most commonly used and most effective treatment for skin cancers. For the treating practitioner, it provides histopathological confirmation of the diagnosis and evidence of margin control. However, because of the relatively benign nature of non-melanoma skin cancers, other non-surgical treatment options have been developed over the last few decades.
Non-melanoma skin cancers -the problem

Basal cell carcinomas
Statistically we know that almost 50% of Caucasian Australians will develop a basal cell carcinoma before the age of 70. once a basal cell carcinoma has developed, it is likely that the same person will develop another within three years. They rarely metastasise but can be locally invasive. 
Solar keratoses and squamous cell carcinomas
Non-surgical treatments
Given the very large numbers of skin cancers seen in Australia and their relatively benign course, non-surgical treatments, which have minimal morbidity associated with the treatment and in many cases a superior cosmetic result, have been investigated. 
Fluorouracil cream (5%)
This has been available for over 30 years. It is used twice a day for three weeks as a treatment for multiple solar keratoses, particularly on the head and scalp areas. The cream usually produces significant inflammation that will take 1-2 weeks to settle. This can be eased with cold compresses and medium potency steroid creams. The greater the inflammatory reaction, www.australianprescriber.com the more efficacious the treatment.
There are also a small number of case reports indicating that 5% fluorouracil cream can be used quite effectively to treat Bowen's disease. This is usually used twice a day for 4-6 weeks with excellent cosmetic results. Significant inflammation tends to occur during the latter period of this treatment course.
As a general rule, fluorouracil cream should not be used as a treatment for basal cell carcinomas as there is little evidence of its efficacy.
Imiquimod cream (5%)
Topical imiquimod has been investigated as a treatment for solar keratoses and basal cell carcinomas over the last 15 years. Initially it was developed and marketed as a treatment for external genital warts. We know that imiquimod activates the local immune system through toll-like receptor 7. This activation causes an inflammatory reaction which clears cancerous and precancerous cells. There is evidence that imiquimod cream is effective as a treatment for solar keratoses. 1 In Australia, it is approved for three 
Radiotherapy
This was the traditional non-surgical option for skin cancers and was used commonly until the late 1960s. Since then, the use of surgical excision as a treatment option has increased significantly.
Radiotherapy provides an excellent alternative in many cases of non-melanoma skin cancer, particularly when surgery is relatively contraindicated. It is also useful as an adjunctive therapy to surgery in difficult or recurrent cases of skin cancer.
Newer treatments
There are a number of new topical treatments that have been investigated over the last few years. one of these promising products is ingenol mebutate, which was originally developed in Australia. Phase III studies have been undertaken for basal cell carcinoma and solar keratoses.
Conclusion
Given the relatively benign nature of basal cell carcinomas, Bowen's disease and solar keratoses, non-surgical treatment options have been investigated as an alternative to surgery.
These have the advantage of often little treatment-associated morbidity for the patient, as well as often a superior cosmetic outcome. The disadvantage is that these treatments are usually not as effective as surgical excision, so regular follow-up (6-12 monthly) over a number of years is required to guard against recurrence at the treatment site.
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